Inclusive Investor Relations, Equity Development

Equity Development

Inclusive Investor Relations

We help companies communicate with all investors. We help all investors better understand those businesses.

Equity Bottom-Up

ECO Animal Health Group plc manufactures, supplies, and markets pharmaceutical products for the animal health markets worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortet and Oxytet for the treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

<ul><li>ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for ECOVAXXIN® MS, the poultry vaccine against Mycoplasma synoviae.</li><li>This important authorisation is key to commercialisation of this, the first of several major products under development to receive approval.</li><li> As the Group notes, the MA has been issued over a month earlier than anticipated.</li></ul>

ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for ECOVAXXIN® MS, the poultry vaccine against Mycoplasma synoviae.This important authorisation is key to commercialisation of this, the first of several major products under development to receive approval. As the Group notes, the MA has been issued over a month earlier than anticipated.

Early EU authorisation for ECOVAXXIN® MS

Global Economist, DeSaque Macro Research

Said Desaque

Global Economist

Delivering Global Macro Investment Insights

DeSaque Macro Research

DeSaque Macro Research Limited was formed by Said DeSaque in April 2012 with the view to delivering global macro investment insights aimed at providing new ideas to clients.

Said DeSaque has over 26 years of experience working as a professional economist in financial services. Prior to establishing DeSaque Macro Research, Said held positions as Senior Economist at Robert W Baird and William Blair. He began his career as a graduate at PaineWebber in 1986, where he eventually became Head of the London Economics Department.

Said takes a very keen interest in international relations, along with their implications for economic development. His research interests include the economic transformation of China and its implications for global capital markets, particularly in the United States. He is a member of Chatham House in London.

The US economy and capital markets have historically been Said’s main focus of attention. He frequently presents his views to institutional investors in diverse geographic locations. In recent years, Said has also been carefully monitoring economic developments in Asia, particularly China and Japan.

Cross Asset Strategy

<ul>
<li>The arrival of the second Trump administration has triggered a wave of commentary justifying lower exposure to US financial markets. Dislike of US trade policy is the main driving force.</li>
<li>The case for greater exposure to Europe is undermined by significant economic stagnation and deindustrialisation in Germany, thereby raising questions about the future economic and financial stability in the region.</li>
<li>Gold is the big winner in 2025 due to portfolio diversification, driven by geopolitical tensions and US dollar weakness. The consensus global economic outlook for 2026 suggests  range-bound gold prices.</li>
</ul>


The arrival of the second Trump administration has triggered a wave of commentary justifying lower exposure to US financial markets. Dislike of US trade policy is the main driving force.
The case for greater exposure to Europe is undermined by significant economic stagnation and deindustrialisation in Germany, thereby raising questions about the future economic and financial stability in the region.
Gold is the big winner in 2025 due to portfolio diversification, driven by geopolitical tensions and US dollar weakness. The consensus global economic outlook for 2026 suggests  range-bound gold prices.


The Diversification Debate: German Stagnation Undermines the Case for Europe, but Gold Wins in 2025

Founder at Stock Spin-off Investing, Stock Spin-Off Investing

Richard Howe

Founder at Stock Spin-off Investing

Stock Spin-Off Investing

Generate attractive returns by taking advantage of inefficiencies in the stock spin-off market.

Stock Spin-offs

Event-Driven

Unilever PLC manufactures personal care products. The Company offers consumer goods, food, detergents, fragrances, beauty, home, and personal care products. Unilever serves customers worldwide.

<ul><li>Unilever (UL) spun off the Magnum Ice Cream Company (MICC) on December 8, 2025.</li><li>Shareholders and ADS holders received one Magnum Share for every five Unilever Shares or Unilever ADS.</li><li>The stock opened at $14.50 and has performed surprisingly well in its first couple weeks of trading.</li></ul>

Unilever (UL) spun off the Magnum Ice Cream Company (MICC) on December 8, 2025.Shareholders and ADS holders received one Magnum Share for every five Unilever Shares or Unilever ADS.The stock opened at $14.50 and has performed surprisingly well in its first couple weeks of trading.

External broker reports, Nordea

Nordea

External broker reports

External broker reports(aggregated public sources)

Nordea is the bank in the Nordics dedicated to serving corporations and institutional customers. Our offering includes a diverse range of financing, cash management and payment services, investment banking, capital markets products, securities services and more. Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Macroeconomics

<ul><li>The headline ESI stood at 103.7 in December, thus above the 100-mark for the third consecutive month and up from 101.5 in November.</li><li>The rise in the ESI was mainly driven by a further improvement of the sentiment in business sector, which is now indicating strong growth.</li><li>The upturn was broad based. The only exception was a downturn in the construction sector, but the confidence indicator is nevertheless above the 100-mark.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

The headline ESI stood at 103.7 in December, thus above the 100-mark for the third consecutive month and up from 101.5 in November.The rise in the ESI was mainly driven by a further improvement of the sentiment in business sector, which is now indicating strong growth.The upturn was broad based. The only exception was a downturn in the construction sector, but the confidence indicator is nevertheless above the 100-mark.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

FX & Rates

<ul><li>EURNOK has risen through December, briefly moving above 12 ahead of Norges Bank’s policy meeting.</li><li>However, from the current levels, we see more limited upside and expect EURNOK to gradually drift lower towards 11.75 during the first quarter.</li><li>The NOK has faced significant headwinds, particularly in December, driven by several factors.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

EURNOK has risen through December, briefly moving above 12 ahead of Norges Bank’s policy meeting.However, from the current levels, we see more limited upside and expect EURNOK to gradually drift lower towards 11.75 during the first quarter.The NOK has faced significant headwinds, particularly in December, driven by several factors.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Europe
Insights on Europe (EU)

Early EU authorisation for ECOVAXXIN® MS

ECO Animal Health Group has announced that the European Commission has adopted the decision granting EU marketing authorisation (MA) for...

Equity Development

The Diversification Debate: German Stagnation Undermines the Case for Europe, but Gold Wins in 2025

The second Trump administration and tariffs provoked the media to argue for diversifying portfolios away from the US to Europe. Secular stagnation...

DeSaque Macro Research

Weekly Update (MICC, 3134, 441A)

Unilever (UL) spun off the Magnum Ice Cream Company (MICC) on December 8, 2025. Shareholders and ADS holders received one Magnum Share...

Richard Howe

Swedish Tendency Survey: Gearing up

The headline ESI stood at 103.7 in December, thus above the 100-mark for the third consecutive month and up from 101.5 in November.

Nordea

We See Limited Upside in EURNOK

EURNOK has risen through December, briefly moving above 12 ahead of Norges Bank’s policy meeting.However, from the current levels, we see more...

Nordea